跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,580 条关于
“RBD-MSA”
全部
6,580
临床试验
4,592
药物
864
机构
493
资讯
631
去年
Intranasal COVID-19 Vaccines Show Superior Mucosal Immunity and Long-Term Protection in Preclinical Studies
去年
XingImaging and SynuSight Receive $3.84M Grant to Advance First α-Synuclein PET Tracer for Parkinson's Disease
去年
Skin Biopsy Test Detects Neurodegenerative Biomarker in 75% of REM Sleep Disorder Patients
去年
Alterity Therapeutics Secures A$40M Funding to Accelerate MSA Drug Development
去年
Ampreloxetine Shows Promise for Neurogenic Orthostatic Hypotension in MSA Patients Without Worsening Supine Hypertension
6个月前
Lundbeck Completes Early Patient Enrollment in Phase 3 Trial for Rare Neurodegenerative Disease MSA
去年
ION464 Shows Promise in MSA, OnabotulinumtoxinA Explored for Essential Tremor, Dietary Challenges in Parkinson's
去年
AskBio Completes Enrollment in Phase 1 Gene Therapy Trial for Rare Neurological Disease MSA-P
去年
Alterity Therapeutics' ATH434 Shows Promise in Multiple System Atrophy Trials
6个月前
XellSmart Secures Fourth Consecutive FDA and NMPA Approval for iPSC Cell Therapy Targeting Rare Neurodegenerative Disease MSA-P
第 1 页,共 64 页
上一页
下一页